9-substituted 6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzobcarbazoles as highly selective and potent anaplastic lymphoma kinase inhibitors

摘要

9-Substituted 6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzobcarbazoles were discovered as highly selective and potent anaplastic lymphoma kinase (ALK) inhibitors by structure-based drug design. The high target selectivity was achieved by introducing a substituent close to the E_0 region of the ATP binding site, which has a unique amino acid sequence. Among the identified inhibitors, compound 13d showed highly selective and potent inhibitory activity against ALK with an IC_(50) value of 2.9 nM and strong antiproliferative activity against KARPAS-299 with an IC_(50) value of 12.8 nM. The compound also displayed significant antitumor efficacy in an established ALK fusion gene-positive anaplastic large-cell lymphoma (ALCL) xenograft model in mice without body weight loss.